Novo NordiskPharmaceutical Companies

ATIVESITE | Work in Progress: Access to Care



By 2030, 60 million people with diabetes in low- and middle-income countries could be without access to insulin.

So how can we change this?

Donations and philanthropy can only go so far. Because once they stop, so does the care. The sustainable answer is to secure and scale long-term access to affordable care – together with partners 🌏

#Sustainability #AccessToCare #DrivingChange

Source Novo Nordisk YouTube

 

1111